Repository logo
Communities & Collections
Research Outputs
Fundings & Projects
People
Statistics
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. KMITL
  3. Publication
  4. Nanomedicine: Drug delivery, molecular diagnosis and artificial organs
Loading...
Thumbnail Image

Nanomedicine: Drug delivery, molecular diagnosis and artificial organs

Author(s)
Yupapin, P. P.
Nathaporn Suwanpayak
Narongchai Moongfangklang
Jalil Ali
Date Issued
August 1, 2012
Type
Book
Abstract
There are many nano-parts composted and integrated to be parts of a human body, which can be investigated and improved by using nanotechnology. Nano-medicine has become the important subject of the world of health and beauty today, in which much of the research in this field has become the challenge and basis for our future developments. In this book, the nano-device known as a PANDA ring resonator is designed and used to form the applications in medicine, especially, nano-medicine. By using the practical optical device and thin film technology, the designed devices and systems can form the human body embedded device, which can be used as the human body embedded devices. There are three major areas of research subjects: drug delivery, molecular diagnosis and therapy and artificial organs integrated to be a monograph book. © 2012 by Nova Science Publishers, Inc. All Rights Reserved.
Citation
Nanomedicine Drug Delivery Molecular Diagnosis and Artificial Organs, 1-170, 2012
Metrics
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback